<?xml version="1.0" encoding="UTF-8"?>
<svg height="774.0" width="586.0" xmlns="http://www.w3.org/2000/svg">
 <g style="fill:none;">
  <path d=" M 310.7340087890625 334.7149963378906 L 320.25799560546875 334.7149963378906 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <text x="200.012,205.592,209.922,213.632,216.612,219.272,223.502,226.162,231.322,235.652,241.132,244.112,247.712,250.00199999999998,252.225,257.385,261.615,266.675,271.835,274.295,278.565,280.798,285.858,288.76800000000003,290.946,295.276,297.736,300.236,302.398,306.728,311.368,315.598,319.198,321.488,323.715,327.425,331.655,336.295,340.625,344.335,349.605,352.065,356.295,359.895,363.53499999999997,365.724,370.784,373.694,375.872,378.852,384.122,388.352,391.012,394.762,396.961,400.561,404.791,409.471,411.645,415.975,421.455,426.765,428.993,434.053,438.283,442.513,447.783,452.943,457.273,460.253,462.913,467.973,473.453" y="92.58600000000001" svg_rhmargin="475.743" style="fill:#000000;font-family:MinionPro-Regular;font-size:10.0px;font-style:NORMAL;font-weight:normal;">Participants: people of all ages, regardless of their sex and occupation.</text>
  <text x="200.012,205.382,209.712,215.192,219.832,225.102,229.432,234.072,238.302,240.59199999999998,242.814,247.144,250.854,253.834,256.494,260.724,263.184,267.414,271.054,273.258,278.418,283.688,288.748,291.208,293.868,297.468,302.738,306.968,312.278,314.53,317.19,322.71,324.849,330.529,336.009,340.649,343.109,345.769,349.369,354.67900000000003,356.936,359.396,363.726,369.206,373.846,379.116,383.446,388.086,392.316" y="111.57799999999997" svg_rhmargin="394.606" style="fill:#000000;font-family:MinionPro-Regular;font-size:10.0px;font-style:NORMAL;font-weight:normal;">Language: articles published in English language.</text>
  <text x="200.012,204.762,207.742,213.012,218.282,222.86200000000002,225.07,230.34,234.57,238.17,240.83,245.47,250.95,253.23999999999998,255.4,259.0,261.98,267.25,272.52,275.18,279.41,283.05,285.277,288.257,293.527,297.857,300.877,303.079,307.409,311.009,314.609,318.839,322.439,326.039,330.269,335.579,337.774,340.754,346.024,350.294,352.514,357.674,361.384,365.614,370.154,374.484,376.944,381.174,386.654,390.884,395.154,397.358,401.688,407.168,412.478,414.65,418.98,422.58,426.18,431.24,435.47,438.13,442.46,445.44,449.67,454.98,457.226,460.096,464.426,468.656,471.636,476.696,480.406,484.046,486.252,491.312,494.22200000000004,496.4,501.88,506.94,512.42,515.92,520.25,525.52,530.79,535.02,538.73,542.96,548.44,552.67,556.9399999999999,559.159,562.139" y="130.62599999999998" svg_rhmargin="567.239" style="fill:#000000;font-family:MinionPro-Regular;font-size:10.0px;font-style:NORMAL;font-weight:normal;">Study design: studies that assessed the prevalence and associated factors of non-adherence to</text>
  <text x="211.974,218.074,223.90400000000002,226.09,234.27,238.5,243.77,246.43,250.66,254.99,257.97,260.63,265.69,271.17,274.77" y="143.60900000000004" svg_rhmargin="277.06" style="fill:#000000;font-family:MinionPro-Regular;font-size:10.0px;font-style:NORMAL;font-weight:normal;">TB medications.</text>
  <text x="200.012,204.762,207.742,213.012,218.282,222.86200000000002,225.07,229.4,233.11,237.34,241.71,243.892,248.222,253.702,259.012,261.183,266.343,270.573,274.283,276.943,282.003,287.273,289.56300000000005,291.74,296.8,302.28,304.74,309.32,311.526,315.126,318.106,323.376,328.646,331.306,335.536,339.176,341.403,345.633,350.693,356.173,361.443,366.713,370.943,373.923,378.153,383.463,385.68,388.34,393.85999999999996,395.998,401.678,404.658,409.928,412.588,417.648,422.808,425.468,429.838,432.111,434.981,438.691,443.751,451.971,454.164,458.914,463.664,468.414,473.204,475.367,478.347,483.447,485.629,490.899,495.129,500.189,503.899,509.169,513.499,517.209,521.789,524.009,528.759,533.509,538.259,543.049,545.212,552.042,556.272,559.982" y="162.601" svg_rhmargin="564.252" style="fill:#000000;font-family:MinionPro-Regular;font-size:10.0px;font-style:NORMAL;font-weight:normal;">Study area and period: only studies conducted in Ethiopia from 1980 to February 2018 were</text>
  <text x="211.974,214.634,220.114,224.344,226.804,232.074,237.344,241.574,246.88400000000001,249.107,251.767,257.287,259.482,262.462,267.732,272.002,274.165,277.875,282.105,286.645,289.305,293.535,300.365" y="175.58299999999997" svg_rhmargin="302.655" style="fill:#000000;font-family:MinionPro-Regular;font-size:10.0px;font-style:NORMAL;font-weight:normal;">included in the review.</text>
  <text x="200.012,206.968,212.677,217.761,221.093,227.678,232.258,235.71,241.911,248.655,251.261,256.346,261.178,264.63,268.707,273.911,278.743,282.196" y="222.413" svg_rhmargin="287.812" style="fill:#000000;font-family:MinionPro-Bold;font-size:12.0px;font-style:NORMAL;font-weight:bold;">Exclusion criteria</text>
  <text x="200.012,203.862,207.835,214.455,219.515,224.995,227.865,232.095,235.805,240.035,245.515,249.745,254.01500000000001,256.251,260.581,265.641,269.241,272.221,275.931,280.261,284.491,287.471" y="245.37300000000005" svg_rhmargin="291.111" style="fill:#000000;font-family:MinionPro-Regular;font-size:10.0px;font-style:NORMAL;font-weight:normal;">• Conference abstracts</text>
  <text x="200.012,203.862,207.835,214.665,218.375,221.355,224.015,228.245,230.705,234.935,238.575,240.773,247.603,252.873,255.533,259.763,265.073,267.249,271.579,275.179,278.779,283.009,286.609,290.209,294.439,299.749,302.001,307.481,312.541,318.021,321.521,325.851,331.121,336.391,340.621,344.331,348.561,354.041,358.271,362.541,364.76,367.74,372.84000000000003,375.021,381.121,386.95099999999996,389.138,392.118,395.828,400.058,404.388,407.368,415.548,419.778,425.258,428.27799999999996,430.467,434.797,442.977,448.037,453.517,458.197,460.457,465.617,469.847,474.907,480.067,482.527,486.79699999999997,488.973,491.433,494.093,498.633,501.293,506.773,511.45300000000003,513.691,520.521,523.181,526.161,531.4709999999999,533.647,541.307,544.697,551.667,553.886,558.946,564.426,566.886" y="264.42100000000005" svg_rhmargin="571.466" style="fill:#000000;font-family:MinionPro-Regular;font-size:10.0px;font-style:NORMAL;font-weight:normal;">• Articles which assessed non-adherence to TB treatment among people living with HIV only</text>
  <text x="200.012,203.862,207.835,214.665,218.375,221.355,224.015,228.245,230.705,234.935,238.575,240.773,247.603,250.263,253.243,258.553,260.729,263.389,268.869,273.099,278.159,286.339,291.499,293.959,298.189,301.169,305.43899999999996,307.671,310.331,315.811,318.681,323.741,327.451,335.631,339.961,342.941,345.601,350.661,356.141,358.43100000000004,360.678,368.858,373.088,376.068,381.338,386.398,391.668,396.728,399.188,404.248,408.888,411.548,415.778,420.108,422.608,424.911,430.071,433.781,438.841,443.901,446.361,450.591,458.771,462.411,464.652,469.712,473.462,475.594,481.074,486.17400000000004,488.35,491.22,496.49,498.95,501.45,503.657,506.637,510.867,515.507,518.5269999999999,520.721,525.051,529.591,533.921,536.581,539.041,543.371,548.431,550.891" y="283.413" svg_rhmargin="555.161" style="fill:#000000;font-family:MinionPro-Regular;font-size:10.0px;font-style:NORMAL;font-weight:normal;">• Articles with incomplete information, methodological problems or no full text available</text>
  <text x="207.835,214.665,218.895,222.605,226.875,229.038,233.368,235.828,239.428,244.528,246.726,250.956,255.596,259.826,262.286,267.556,272.826,277.056,282.326,284.61600000000004,286.808,291.868,296.098,300.328,304.658,309.928,313.528,317.798,320.03,323.01,328.28,330.94,334.58,336.754,344.934,349.264,353.844,356.029,358.489,361.149,369.329,371.989,375.00899999999996,377.232,380.212,385.482,389.752,391.916,396.246,401.726,406.056,408.516,413.056,416.656,420.886,424.486" y="296.396" svg_rhmargin="426.776" style="fill:#000000;font-family:MinionPro-Regular;font-size:10.0px;font-style:NORMAL;font-weight:normal;">were also excluded, because this may limit the analyses.</text>
  <text x="200.012,209.092,214.669,218.745,224.361,226.941,232.145,237.854,241.93,246.762,252.339,257.423,261.499,264.952,271.152,277.89599999999996,280.516,286.092,292.796,299.42,302.059,308.391,314.976,320.552,323.885,327.337,331.413,337.029,339.589,345.165,349.746,354.326,359.53,364.111,368.691,378.767,383.972,390.676" y="343.225" svg_rhmargin="394.792" style="fill:#000000;font-family:MinionPro-Bold;font-size:12.0px;font-style:NORMAL;font-weight:bold;">Data extraction and quality assessment</text>
  <text x="200.012,206.112,211.382,215.65200000000002,217.813,223.083,227.413,230.393,234.763,236.975,241.205,245.845,248.825,252.535,256.865,261.095,264.075,266.735,271.795,277.315,279.551,286.381,290.711,294.351,296.502,301.772,306.832,312.312,316.582,318.782,323.842,328.42199999999997,330.631,333.611,340.441,345.541,347.696,350.356,355.836,360.376,364.606,368.206,371.186,373.846,378.486,382.816,385.796,390.856,394.566,398.20599999999996,400.476,403.136,408.616,413.886,418.116,423.276,427.506,432.986,438.256,442.486,447.966,450.946,453.406,457.986,460.23,465.5,469.1,471.76,477.24,481.92,484.098,493.008,495.668,499.898,503.608,508.668,512.268,517.328,520.198,523.218,525.483,531.163,535.803,540.033,544.263,546.763,548.954,555.784,558.444,561.424,566.7339999999999,568.91" y="360.176" svg_rhmargin="573.28" style="fill:#000000;font-family:MinionPro-Regular;font-size:10.0px;font-style:NORMAL;font-weight:normal;">The data extraction was done by two investigators independently using Microsoft Excel with a</text>
  <text x="200.012,202.992,208.052,213.112,215.572,217.862,220.024,226.124,231.394,234.054,237.694,239.923,242.903,247.963,253.023,255.523,257.668,260.328,265.808,270.038,272.498,277.768,283.038,287.268,292.578,294.801,297.461,302.941,305.811,310.871,314.581,322.761,327.091,330.071,332.731,337.791,343.311,345.598,350.658,356.178,358.354,361.334,366.604,370.87399999999997,373.037,377.367,382.637,385.617,390.887,395.947,399.657,401.947,404.161,408.701,412.931,417.261,421.011,423.153,428.213,431.12300000000005,433.301,438.461,443.731,448.791,451.251,453.911,458.141,462.471,465.451,468.111,473.171,478.651,480.94100000000003,483.191,486.901,491.131,495.771,498.431,503.491,508.971,511.261,513.521,517.121,520.101,525.371,530.641,535.221,537.389,542.659,546.889,550.489,553.149,557.789,563.269" y="373.215" svg_rhmargin="565.559" style="fill:#000000;font-family:MinionPro-Regular;font-size:10.0px;font-style:NORMAL;font-weight:normal;">tool. This tool included information on the author, year of publication, region, study design,</text>
  <text x="200.012,203.612,207.942,216.122,221.282,223.742,228.012,230.229,233.829,236.489,240.609,244.839,247.129,249.334,251.994,257.474,261.704,264.164,269.434,274.704,278.934,284.244,286.411,291.571,295.901,299.611,302.591,305.251,309.481,312.141,317.301,321.631,327.111,330.091,333.691,335.981,338.285,342.615,348.095,353.40500000000003,355.576,361.056,366.326,374.506,379.566,383.796,387.546,389.761,394.821,397.73100000000005,399.909,405.069,409.399,412.379,415.039,419.269,424.749,427.729,431.36899999999997,433.585,440.415,443.075,446.055,451.365,453.541,459.021,464.081,469.561,473.061,477.391,482.661,487.931,492.161,495.871,500.101,505.581,509.811,514.081,516.356,519.336,523.046,527.276,531.606,534.586,542.766,546.996,552.476,555.456,557.746,559.953,566.053" y="386.197" svg_rhmargin="571.883" style="fill:#000000;font-family:MinionPro-Regular;font-size:10.0px;font-style:NORMAL;font-weight:normal;">sample size, included participants, and number of patients with non-adherence treatment, TB</text>
  <text x="200.012,205.172,208.882,213.112,217.652,221.982,224.442,228.672,234.152,238.382,242.65200000000002,244.855,248.565,252.895,255.875,260.105,263.745,265.945,270.275,275.755,281.065,283.236,286.946,289.606,293.206,298.206,300.414,303.284,307.614,311.844,314.824,319.884,323.594,327.234,329.441,333.041,335.701,340.341,345.821,348.481,351.351,354.011,358.241,362.571,368.051,371.031,373.491,378.07099999999997,380.351,384.061,388.291,390.751,395.081,398.061,402.291,407.601,409.774,412.754,417.85400000000004,420.035,425.515,430.575,436.055,439.555,443.885,449.155,454.425,458.655,462.365,466.595,472.075,476.305,480.575,482.794,485.454,490.974,493.169,499.269,505.099,507.285,512.445,516.775,519.755,522.415,526.645,532.125,535.105,538.705" y="399.18" svg_rhmargin="540.995" style="fill:#000000;font-family:MinionPro-Regular;font-size:10.0px;font-style:NORMAL;font-weight:normal;">prevalence rates and risk factors significantly related to non-adherence in TB patients.</text>
  <text x="211.974,218.804,226.984,232.044,237.524,242.204,244.458,247.438,252.708,256.978,259.142,263.472,267.182,270.162,272.822,277.052,279.512,283.742,287.382,289.586,292.246,297.516,301.746,307.226,310.206,312.866,315.736,318.396,322.626,327.896,330.18600000000004,332.445,335.425,338.085,341.065,343.525,347.755,351.395,353.592,357.922,363.402,368.712,370.883,375.213,380.273,383.873,386.853,390.563,394.893,399.123,402.103,405.743,407.96,414.79,419.02,422.73,427.0,429.163,432.873,437.103,441.643,444.303,448.533,455.363,459.593,464.903,467.147,470.127,475.22700000000003,477.408,481.118,485.348,488.328,492.038,494.698,498.928,503.468,507.738,509.95,513.55,516.53,521.8,527.07,529.73,533.96,537.6,539.77,544.83,550.35,552.526,555.506,560.776" y="412.219" svg_rhmargin="565.046" style="fill:#000000;font-family:MinionPro-Regular;font-size:10.0px;font-style:NORMAL;font-weight:normal;">Among the articles identified, titles and abstracts were reviewed to retrieve studies on the</text>
  <text x="200.012,205.172,208.882,213.112,217.652,221.982,224.442,228.672,234.152,238.382,242.65200000000002,244.855,249.915,252.825,255.003,260.483,265.543,271.023,274.523,278.853,284.123,289.393,293.623,297.333,301.563,307.043,311.273,315.543,317.762,320.742,325.84200000000004,328.023,334.123,339.953,342.14,345.12,348.83,353.06,357.39,360.37,368.55,372.78,378.26,381.24,383.53000000000003,385.736,392.566,396.276,399.256,401.916,406.146,408.606,412.836,416.476,418.731,421.601,426.661,431.931,437.411,442.721,444.923,448.633,452.863,455.323,459.553,464.093,468.423,473.903,476.923,479.109,484.169,488.74899999999997,490.901,493.881,496.541,499.521,501.981,506.251,508.476,512.806,518.286,523.5959999999999,525.767,530.097,535.157,538.757,541.737,545.447,549.777,554.007" y="425.202" svg_rhmargin="557.027" style="fill:#000000;font-family:MinionPro-Regular;font-size:10.0px;font-style:NORMAL;font-weight:normal;">prevalence of non-adherence to TB treatment. Articles found relevant by title and abstract</text>
  <text x="200.012,203.612,207.842,211.552,215.782,220.012,225.492,229.722,235.032,237.202,240.072,245.132,248.882,251.091,253.961,259.231,261.691,264.191,266.342,269.322,273.552,278.192,281.212,283.406,287.116,291.346,295.886,298.546,302.776,309.646,311.866,314.736,319.796,323.546,325.756,329.986,332.446,335.106,339.746,342.406,347.466,350.126,352.586,355.246,358.226,362.766,365.05600000000004,367.255,373.355,378.625,382.895,385.113,390.173,395.443,399.773,402.233,404.893,407.873,412.453,414.65,419.71,422.62,424.797,429.027,431.487,434.147,438.787,441.447,446.507,448.967,453.23699999999997,455.468,459.068,462.048,467.318,472.588,475.248,479.478,483.118,485.345,492.175,496.505,500.145,502.296,506.626,510.226,513.826,518.056,521.656,525.256,529.486,534.7959999999999,537.049,541.379,546.019,550.349,553.009,558.489,562.089" y="438.184" svg_rhmargin="565.109" style="fill:#000000;font-family:MinionPro-Regular;font-size:10.0px;font-style:NORMAL;font-weight:normal;">screened for full text review for eligibility. The quality of eligible studies was assessed against</text>
  <text x="200.012,205.172,208.882,213.112,218.382,222.612,225.482,228.142,233.622,237.852,243.162,245.366,248.026,253.506,257.736,260.196,265.466,269.066,271.726,276.786,282.306,284.54,288.77,292.48,295.14,298.12,302.35,306.06,308.72,313.09000000000003,315.324,319.654,325.134,330.444,332.615,335.595,340.865,345.135,347.299,352.359,357.629,361.959,364.419,367.079,370.059,374.639,376.836,381.166,384.766,388.366,392.596,396.196,399.796,407.976,412.206,417.686,420.70599999999996,422.983,425.963,431.023,436.083,438.583,440.785,443.655,448.715,452.465,454.618,458.848,462.558,467.618,471.218,474.858,477.068,480.668,484.898,489.128,492.108,494.768,499.828,505.308,509.638,512.1379999999999,514.372,517.972,520.952,526.222,531.492,534.152,538.382,542.0219999999999,544.192,549.152,554.632,559.692,566.522" y="451.224" svg_rhmargin="572.042" style="fill:#000000;font-family:MinionPro-Regular;font-size:10.0px;font-style:NORMAL;font-weight:normal;">predefined inclusion criteria and the quality assessment tool for cross sectional studies known</text>
  <text x="200.012,204.342,207.982,210.159,217.509,221.739,228.569,232.799,237.129,240.729,243.709,246.169,250.399,253.899,261.359,264.339,267.319,271.649,278.479,282.849,285.107,289.857,294.087,298.417,300.877,305.147,307.331,310.721,315.471,320.221,323.611,325.901,328.08,335.74,338.4,343.04,348.35,350.587,355.647,360.917,365.247,367.707,370.367,373.347,377.92699999999996,380.124,384.454,388.164,391.144,393.804,398.034,400.494,404.724,408.364,410.568,417.398,421.628,425.338,429.608,431.827,437.097,441.327,444.307,448.537,452.247,460.427,463.087,468.567,472.797,478.107,480.299,482.959,485.869,488.066,491.666,495.896,500.226,502.686,506.95599999999996,509.156,512.756,516.986,522.046,525.756,530.026,532.23,539.06,543.39,547.03,549.181,553.971,556.154,560.484,565.964" y="464.206" svg_rhmargin="571.274" style="fill:#000000;font-family:MinionPro-Regular;font-size:10.0px;font-style:NORMAL;font-weight:normal;">as Newcastle-Ottawa Scale [37]. High quality articles were determined if scale score was 6 and</text>
  <text x="200.012,204.342,209.402,214.462,219.002,223.27200000000002,225.466,230.526,235.796,238.816,241.0,246.06,248.97,251.148,255.898,260.648,262.93800000000005,265.095,271.195,278.025,283.125,285.334,287.994,293.474,298.014,302.244,305.844,308.824,311.484,316.124,320.454,323.434,328.494,332.204,335.844,338.115,342.345,347.405,352.885,358.155,363.425,367.655,370.635,374.865,380.175,382.391,385.371,390.641,394.911,397.075,400.675,404.905,407.365,411.595,415.825,418.805,421.465,426.525,432.005,434.295,436.533,440.763,445.403,448.383,452.093,456.423,460.653,463.633,466.293,471.353,476.873,479.052,483.382,488.862,494.172,496.4,501.46,506.73,511.06,513.52,516.18,519.16,523.74,525.937,530.267,533.867,537.467,541.697,545.297,548.897,557.077,561.307,566.787" y="477.189" svg_rhmargin="569.807" style="fill:#000000;font-family:MinionPro-Regular;font-size:10.0px;font-style:NORMAL;font-weight:normal;">above out of 10. Two investigators conducted the selection, extraction and quality assessment</text>
  <text x="200.012,205.072,207.982,210.159,214.489,218.199,221.179,223.839,228.069,230.529,234.759,238.39899999999997,240.603,243.263,248.743,254.013,258.243,263.403,267.633,273.113,278.383,282.613,288.093,291.073,293.533,298.073,300.363,302.625,306.015,311.495,315.725,320.785,326.265,329.865,332.525,336.125,339.105,343.335,348.815,353.045,355.705,359.935,363.575,365.837,370.897,375.127,378.107,384.937,389.167,393.397,398.917,401.1,404.08,409.35,413.62,415.783,418.443,423.923,428.463,432.693,436.293,439.273,441.933,446.573,450.903,453.883,458.943,462.653,466.293,468.564,475.394,479.624,483.334,487.604,489.824,493.424,498.484,500.944,505.484,509.714,515.024,517.206,522.266,526.846,528.998,534.268,536.928,540.528,544.758,550.028,553.628,557.228,559.888,564.948" y="490.172" svg_rhmargin="570.468" style="fill:#000000;font-family:MinionPro-Regular;font-size:10.0px;font-style:NORMAL;font-weight:normal;">of articles independently. Inconsistencies between the investigators were solved by discussion</text>
  <text x="200.012,204.342,209.822,215.132,217.303,221.633,225.343,228.323,230.983,235.213,237.673,241.903,245.54299999999998,247.747,254.577,258.807,262.517,266.787,268.95,271.61,277.09,281.32,283.78,289.05,294.32,298.55,303.86,306.083,310.413,313.283,316.263,320.493,324.243,326.436,330.666,335.726,341.206,344.806,349.036,354.516,358.116,363.386,366.986" y="503.211" svg_rhmargin="369.276" style="fill:#000000;font-family:MinionPro-Regular;font-size:10.0px;font-style:NORMAL;font-weight:normal;">and articles were included after consensus.</text>
  <text x="200.012,209.212,215.797,219.873,224.957,231.158,241.234,246.478,249.051,259.127,264.331,269.908,274.488,281.073,285.905,291.109,301.186,306.39,313.094" y="530.992" svg_rhmargin="317.21" style="fill:#000000;font-family:MinionPro-Bold;font-size:12.0px;font-style:NORMAL;font-weight:bold;">Outcome measurement</text>
  <text x="200.012,206.842,212.322,215.302,217.962,221.462,227.562,233.39200000000002,235.614,238.594,242.304,246.534,250.864,253.844,262.024,266.254,271.734,274.75399999999996,276.943,281.273,286.543,291.813,296.043,299.753,303.983,309.463,313.693,317.96299999999997,320.2,323.8,326.78,331.11,334.09,339.36,343.0,345.201,352.031,356.361,360.001,362.152,365.132,370.402,374.67199999999997,376.892,381.952,387.222,390.202,394.432,399.492,407.672,411.942,414.139,418.679,423.009,426.719,429.379,433.709,438.769,441.229,445.49899999999997,447.701,452.971,455.631,459.861,465.131,470.191,473.171,478.231,486.411,489.071,493.191,497.421,502.731,505.017,509.347,512.987,515.165,519.495,524.765,530.035,534.265,537.975,542.205,547.685,550.7049999999999,552.923,557.253,562.733" y="548.0" svg_rhmargin="568.043" style="fill:#000000;font-family:MinionPro-Regular;font-size:10.0px;font-style:NORMAL;font-weight:normal;">Anti-TB treatment adherence status was the outcome variable dichotomized as adherent and</text>
  <text x="200.012,205.492,210.552,216.032,219.532,223.862,229.132,234.402,238.632,242.342,246.572,252.052,255.032,257.322,259.539,266.409,268.609,273.769,278.099,281.079,283.739,287.969,293.449,296.469,298.657,303.717,307.947,310.407,315.467,320.947,325.587,328.247,333.727,338.407,340.666,343.646,348.74600000000004,350.87,355.1,357.76,360.74,366.01,370.24,373.99,376.212,378.872,384.352,387.332,391.562,397.042,400.642,403.302,407.842,412.11199999999997,414.309,419.369,423.119,425.308,429.538,434.598,440.078,443.058,445.718,451.198,456.468,460.798,463.778,466.438,471.498,477.018,479.279,484.439,489.709,494.039,497.639,501.909,504.11,509.38,514.86,520.13,524.36,528.11,530.302,535.782,540.012,546.882,549.068,554.128" y="560.982" svg_rhmargin="557.878" style="fill:#000000;font-family:MinionPro-Regular;font-size:10.0px;font-style:NORMAL;font-weight:normal;">non-adherent. A patient belonging to either intensive or continuation phase under new or</text>
  <text svg_rhmargin="331.679" x="200.012,203.722,207.952,210.932,214.642,218.872,223.202,226.182,234.362,238.592,244.072,247.092,249.277,252.987,257.217,261.857,264.517,272.697,276.927,282.447,284.71,291.54,296.81,301.91,304.099,312.279,314.939,318.539,322.139,326.369,331.67900000000003" y="574.021" style="fill:#000000;font-family:MinionPro-Regular;font-size:10.0px;font-style:NORMAL;font-weight:normal;">retreatment regimen who missed </text>
  <text x="333.863" y="574.021" svg_rhmargin="341.563" style="fill:#000000;font-family:TeX_CM_Maths_Symbols;font-size:10.0px;font-style:NORMAL;font-weight:normal;">�</text>
  <text x="341.563,346.313,351.063,358.663,360.905,365.965,368.875,371.053,374.033,379.303,383.573,385.736,388.716,393.776,396.756,401.086,403.586,405.749,410.909,414.619,418.849,422.449,426.679,430.389,433.049,438.109,442.339,447.649,449.912,455.182,460.242,463.842,468.11199999999997,470.265,477.095,481.425,485.065,487.273,491.503,496.563,502.043,505.643,508.303,513.573,517.803,521.513,525.743,531.053,533.307,537.637,541.2769999999999,543.455,548.935,553.995,559.475" y="574.021" svg_rhmargin="563.015" style="fill:#000000;font-family:MinionPro-Regular;font-size:10.0px;font-style:NORMAL;font-weight:normal;">10% of the total prescribed dose was considered as non-</text>
  <text x="200.012,204.342,209.612,214.882,219.112,222.822,227.052,232.532,235.512,237.802,239.98,245.25,250.31,254.06,256.251,259.851,265.011,270.281,273.261,278.531,286.75100000000003,288.962,291.832,296.892,299.352,301.812,306.872,313.742,315.948,321.218,326.378,328.668,330.858,336.018,340.348,343.328,345.988,350.218,355.698,358.678,362.318,364.533,371.363,376.633,381.733,383.922,392.102,394.762,398.362,401.962,406.192,411.502,413.742,418.802,424.282,428.55199999999996,430.75,435.08,440.56,445.87,448.041,456.221,461.281,464.991,469.26099999999997,471.455,475.055,480.215,485.485,488.465,493.735,501.95500000000004,504.167,507.147,511.377,514.977,517.957,521.597,523.783,530.613,534.843,538.553,542.823,544.986,549.216,554.276,559.756,563.356,566.016,571.286" y="587.004" svg_rhmargin="574.826" style="fill:#000000;font-family:MinionPro-Regular;font-size:10.0px;font-style:NORMAL;font-weight:normal;">adherent. For sputum follow up, patients who missed one and more sputum tests were consid-</text>
  <text x="200.012,204.242,207.952,212.182,217.492,219.57,223.9,227.54,229.662,235.142,240.202,245.682,249.182,253.512,258.782,264.052,268.282,271.992,276.222,281.702,284.682,286.97200000000004,289.076,295.176,300.446,304.716,306.82,311.98,315.69,318.35,326.53,330.86,334.57,339.15,341.289,346.349,351.619,354.599,358.829,363.889,372.069,376.339,378.48,383.54,386.45000000000005,388.571,391.551,396.821,399.481,403.121,405.182,408.782,411.762,417.032,422.302,426.882,428.993,435.823,440.153,443.793,445.944,448.924,454.194,458.464,460.514,465.674,469.384,473.614,478.154,482.484,484.944,489.174,494.654,498.884,503.154,505.301,510.361,513.271,515.392,520.872,525.932,531.412,534.912,539.242,544.512,549.782,554.012,557.722,561.952,567.432,571.662" y="599.987" svg_rhmargin="575.932" style="fill:#000000;font-family:MinionPro-Regular;font-size:10.0px;font-style:NORMAL;font-weight:normal;">ered as non-adherent. The primary outcome of this study was the prevalence of non-adherence</text>
  <text x="200.012,202.992,208.09199999999998,210.273,216.373,222.203,224.389,227.369,231.079,235.309,239.639,242.619,250.799,255.029,260.509,263.489,265.779,267.986,274.086,279.356,283.626,285.787,290.947,294.657,298.887,303.427,307.757,310.217,314.447,319.927,324.157,328.42699999999996,330.631,337.461,341.791,345.431,347.639,351.869,356.199,358.659,362.889,368.159,370.619,374.949,377.929,382.159,387.469,389.705,394.765,399.34499999999997,401.497,406.767,409.427,413.967,416.627,421.897,424.557,430.037,434.717,436.986,439.966,445.236,449.506,451.67,457.15,462.42,470.6,475.66,479.89,483.64,485.855,490.915,493.82500000000005,496.003,502.103,507.933,510.12,515.28,519.61,522.59,525.25,529.48,534.96,537.94,541.58,543.795,550.625,555.895" y="613.0260000000001" svg_rhmargin="560.995" style="fill:#000000;font-family:MinionPro-Regular;font-size:10.0px;font-style:NORMAL;font-weight:normal;">to TB treatment. The prevalence was calculated by dividing the number of TB patients who</text>
  <text x="200.012,205.282,207.942,213.252,215.432,220.912,225.972,228.99200000000002,231.136,235.466,240.736,246.006,250.236,253.946,258.216,260.446,265.506,270.08599999999996,272.238,275.218,280.488,284.758,286.978,289.958,295.018,297.998,302.328,304.828,306.99,312.47,317.74,325.92,330.98,335.21,338.96,341.176,346.236,349.146,351.324,354.924,357.904,363.174,368.444,373.024,375.191,378.791,384.061,389.121,391.681,395.911,400.141,403.121,406.76099999999997,408.98,417.16,422.43,424.89,427.87,430.53,435.69,438.15,440.81,445.04,450.35,452.634,457.694,462.274,464.426,469.176,473.926,478.676,480.966,483.134,489.234,494.504,498.774,500.992,504.592,508.822,513.052,518.112,523.592,528.9019999999999,531.096,536.156,541.426,544.406,548.636,553.696,561.876" y="626.008" svg_rhmargin="566.146" style="fill:#000000;font-family:MinionPro-Regular;font-size:10.0px;font-style:NORMAL;font-weight:normal;">did not adhere by the total number of study subjects multiplied by 100. The second outcome</text>
  <text x="200.012,204.242,209.302,214.782,218.382,221.042,226.312,230.542,234.252,238.482,243.792,245.989,248.649,254.169,256.364,259.344,264.614,267.274,270.914,273.088,276.688,281.228,284.828,287.808,292.038,300.218,304.548,307.528,310.188,314.45799999999997,316.741,320.451,324.681,329.221,331.881,336.111,342.981,345.144,349.474,354.954,360.264,362.436,370.616,374.846,377.826,382.156,385.656,389.986,395.466,399.796,402.256,406.796,410.396,413.056,416.69599999999997,418.958,425.788,430.118,433.758,435.966,440.336,442.542,446.252,448.912,452.512,457.512,459.663,462.533,466.863,471.093,474.073,479.133,482.883,485.118,488.098,493.368,497.698,500.71799999999996,502.863,505.523,509.163,511.367,515.697,519.297,522.897,527.957,532.187,534.847,539.177,542.157,546.387,551.6969999999999,553.943,560.773,563.433,566.413" y="638.991" svg_rhmargin="571.723" style="fill:#000000;font-family:MinionPro-Regular;font-size:10.0px;font-style:NORMAL;font-weight:normal;">considered in this systematic review and meta-analysis was a risk factor that is associated with</text>
  <text x="200.012,205.492,210.552,216.032,219.532,223.862,229.132,234.402,238.632,242.342,246.572,252.052,256.282,260.55199999999996,262.77,265.75,270.85,273.032,279.132,284.962,287.148,290.128,293.838,298.068,302.398,305.378,313.558,317.788,323.268,326.248,328.538,330.745,336.015,341.075,344.825,347.015,349.995,355.265,359.53499999999997,361.699,366.029,371.509,375.839,378.299,382.839,386.439,389.099,392.739,394.977,400.037,402.947,405.125,408.105,413.375,417.645,419.809,423.519,426.179,429.779,434.779,436.986,439.856,444.186,448.416,451.396,456.456,460.166,463.766,466.05600000000004,468.281,475.111,479.381,481.547,485.777,490.837,496.317,499.917,502.577,507.847,512.077,515.787,520.017,525.327,527.524,531.854,537.334,542.6439999999999,544.872,549.102,554.162,556.622" y="651.9739999999999" svg_rhmargin="560.162" style="fill:#000000;font-family:MinionPro-Regular;font-size:10.0px;font-style:NORMAL;font-weight:normal;">non-adherence to TB treatment. For the analysis of the risk factors, we considered and col-</text>
  <text x="200.012,202.472,206.702,210.932,213.912,218.142,223.452,225.637,229.347,232.007,235.607,240.607,242.758,245.628,249.958,254.188,257.168,262.228,265.938,269.578,271.841,278.671,283.941,286.601,290.831,296.141,298.316,305.146,309.376,313.086,317.356,319.519,327.699,331.929,337.409,340.389,343.049,348.109,353.589,357.819,363.129,365.384,368.044,373.56399999999996,375.758,378.738,385.568,390.668,392.823,397.883,401.633,403.821,412.001,417.061,420.771,425.041,427.235,430.835,433.815,439.085,444.355,447.015,451.245,454.885,457.112,462.172,466.752,468.904,471.364,476.424,481.484,486.444,489.104,494.584,499.264,501.503,505.833,508.853,511.027,514.007,519.277,523.547,525.71,528.69,535.52,540.62,542.775,547.835,552.4150000000001,554.623,557.603,564.433" y="665.013" svg_rhmargin="569.533" style="fill:#000000;font-family:MinionPro-Regular;font-size:10.0px;font-style:NORMAL;font-weight:normal;">lected risk factors which were mentioned in two or more studies by looking at the two by two</text>
  <text x="200.012,202.992,207.322,212.382,214.842,219.072,222.712,224.9,229.96,232.87,235.047,238.027,243.297,247.567,249.731,252.601,256.931,261.161,264.141,269.201,272.911,276.551,278.757,282.467,286.697,291.857,296.917,300.627,303.607,307.837,313.147,315.381,318.041,323.561,325.756,329.986,334.316,338.546,343.856,345.995,349.595,352.575,357.845,363.115,367.655,369.945,372.187,377.867,381.367,389.547,393.877,396.537,398.997,402.637,404.842,411.672,415.902,419.612,423.882,426.045,429.645,433.875,439.355,442.375,444.583,447.563,452.663,454.845,457.825,463.095,467.365,469.528,473.758,478.818,482.528,486.238,490.468,494.068,499.228,504.288,509.768,515.038,517.698,523.178,527.858,530.132,535.192,538.942,541.131,544.001,546.661,550.371,553.971" y="677.996" svg_rhmargin="556.991" style="fill:#000000;font-family:MinionPro-Regular;font-size:10.0px;font-style:NORMAL;font-weight:normal;">tables of the factors reported in each study. E-mails were sent to the corresponding or first</text>
  <text x="200.012,204.342,209.612,212.592,217.862,222.922,226.632,230.272,232.496,237.556,240.466,242.644,245.624,250.894,255.16400000000002,257.328,260.928,263.908,269.178,274.448,277.108,281.338,284.978,287.148,292.208,295.958,298.146,302.476,307.536,311.136,314.116,317.826,322.156,326.386,329.366,333.006,335.223,338.093,343.153,346.903,349.113,357.293,359.953,363.553,367.153,369.813,375.293,379.973,382.221,384.881,390.361,393.231,398.291,402.001,410.181,414.511,417.491,420.151,425.211,430.731,432.961,437.291,442.771,448.081,450.252,454.622,456.829,463.659,467.989,470.649,473.629,476.289,481.769,486.449,488.633,491.613,494.273,502.453,506.72299999999996,508.929,513.989,516.899,519.077,523.827,528.987,533.7769999999999,535.972,542.802,547.032,551.262,556.222" y="690.978" svg_rhmargin="559.862" style="fill:#000000;font-family:MinionPro-Regular;font-size:10.0px;font-style:NORMAL;font-weight:normal;">authors of the studies or abstracts for missing information and a waiting time of 3–4 weeks</text>
  <text x="200.012,206.842,211.072,214.782,219.05200000000002,221.215,224.195,228.525,233.485,237.715,243.235,245.422,248.292,253.352,257.102,259.312,262.292,267.562,271.832,273.995,277.705,281.935,285.535,290.695,295.755,301.235,304.835,309.065,312.665,314.95500000000004,317.195,320.585,323.495,325.642,328.622,333.892,338.122,341.832,346.102,348.319,355.149,359.379,363.089,367.359,369.522,375.002,380.10200000000003,382.278,385.988,390.218,393.818,398.978,404.038,409.518,413.118,417.348,420.948,423.238,425.478,432.308,436.578,438.744,442.974,447.614,451.844,454.304,459.574,464.844,469.074,474.384,476.614,479.594,484.864,489.13399999999996,491.298,494.898,497.878,503.148,508.418,512.998,515.222,520.282,524.032,526.164,529.144,534.414,538.684,540.904,546.064,550.394,554.104,558.434,566.614,570.844" y="704.017" svg_rhmargin="574.384" style="fill:#000000;font-family:MinionPro-Regular;font-size:10.0px;font-style:NORMAL;font-weight:normal;">were taken for the responses. If there were no responses, we excluded the study or the parame-</text>
  <text x="200.012,202.992,207.222,210.972,213.107,216.087,221.357,225.687,228.70700000000002,230.909,237.739,242.069,245.70899999999997,247.917,253.397,258.457,261.477,263.621,267.951,272.491,276.821,279.481,281.941,286.271,291.331,293.791,298.021" y="717.0" svg_rhmargin="300.311" style="fill:#000000;font-family:MinionPro-Regular;font-size:10.0px;font-style:NORMAL;font-weight:normal;">ter that was not available.</text>
  <path d=" M 576.0 737.0999755859375 L 36.0 737.0999755859375 L 36.0 737.5999755859375 L 576.0 737.5999755859375" style="fill:none;stroke:#000000;stroke-width:9.999999747378752E-5;"/>
  <path d="M310.734 465.285 L320.257 465.285 M576.0 62.9 L36.0 62.9 L36.0 62.4 L576.0 62.4 " style="fill:none;stroke:#000000;stroke-width:9.999999747378752E-5;"/>
  <rect style="stroke:blue;stroke-width:0.3;" x="36.0" y="35.042" height="23.698" width="107.15" title="4"/>
  <text x="36.0" y="35.042" class="image" id="image.4.1" width="107" height="23">image.4.1.36_143.35_59</text>
  <text x="279.836,285.124,287.748,292.124,296.084,300.46,302.164,306.54,310.916,314.758,319.174,320.881,325.257,329.633,334.049,335.734,340.11,344.486,346.694,351.07,353.694,360.318,362.022,366.292,370.668,375.044,377.252,381.252,382.96,387.335,389.58299999999997,391.293,395.669,400.045,402.253,403.957,406.581,408.789,413.165,417.541,421.794,424.418,428.378,432.754,434.458,438.834,442.794,444.498,448.498,450.197,452.405,455.029,459.405,463.781,465.989,472.613,476.989,481.365,483.613,485.233,489.609,493.985,498.361,500.985,505.361,509.737,514.113,518.489,521.006,525.382,529.758,533.718,538.134,539.771,541.475,545.8910000000001,547.595,552.883,555.091,559.467,561.171,565.547,569.923,571.627" y="54.20500000000004" svg_rhmargin="576.043" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">Prevalence and determinants of anti-tuberculosis treatment non-adherence in Ethiopia</text>
  <path d=" M 36.0 48.00019836425781 L 576.0 48.00019836425781 L 576.0 47.50019836425781 L 36.0 47.50019836425781" style="fill:none;stroke:#000000;stroke-width:9.999999747378752E-5;"/>
  <path d=" M 81.58110046386719 34.92279815673828 L 237.88299560546875 34.92279815673828 Z " style="fill:none;stroke:#000000;stroke-width:9.999999747378752E-5;"/>
  <text x="36.0,41.288,45.664,51.872,57.2,58.847,65.055,70.759,76.087,77.782,79.862,81.58,85.956,88.164,90.372,94.748,98.708,100.916,103.124,105.332,109.708,114.084,115.788,117.996,122.372,124.893,129.269,131.477,135.853,140.229,142.437,146.813,151.189,155.451,159.827,162.035,163.739,168.115,172.491,175.115,179.491,183.867,185.571,187.779,192.155,196.44,200.816,205.191,207.399,211.775,216.151,220.527,224.903,229.151,233.527,237.94299999999998,245.876,249.836,254.212,258.588,262.964,267.34,269.964,273.964,275.639,280.015,284.391,286.639,288.338,292.714,297.09,301.466,305.882,557.118,561.5340000000001,563.241,565.489,567.209,571.585" y="764.0" svg_rhmargin="576.001" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">PLOS ONE | https://doi.org/10.1371/journal.pone.0210422 January 10, 2019 4 / 15</text>
 </g>
</svg>
